Geldanamycin was initially shown to have moderate activity against protozoa, bacteria, and fungi [5], but it was later found to possess potent anticancer activity against a wide range of human cancers through its inhibition of Hsp90 [6]. The gene discussed is HSP90AA1; the disease is cancer.